Supplemental material
Drug Delivery
Volume 26, 2019 - Issue 1
Open access
2,519
Views
32
CrossRef citations to date
0
Altmetric
Research Article
pH sensitive peptide functionalized nanoparticles for co-delivery of erlotinib and DAPT to restrict the progress of triple negative breast cancer
Xu Wana Department of Pharmacy, South Campus, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, People's Republic of China; View further author information
, Chaoqian Liub Department of General Surgery, Changhai Hospital The Second Military Medical University, Shanghai, People's Republic of ChinaView further author information
, Yinan Lina Department of Pharmacy, South Campus, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, People's Republic of China; View further author information
, Jie Fua Department of Pharmacy, South Campus, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, People's Republic of China; View further author information
, Guohong Lua Department of Pharmacy, South Campus, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, People's Republic of China; Correspondence[email protected] [email protected]
View further author information
& View further author information
Zhengmao Lub Department of General Surgery, Changhai Hospital The Second Military Medical University, Shanghai, People's Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
View further author information
Pages 470-480
|
Received 07 Jan 2019, Accepted 28 Jan 2019, Published online: 08 Apr 2019
Related Research Data
Triple negative breast cancer: looking for the missing link between biology and treatments.
Source:
Impact Journals, LLC
In vivo targeting of breast cancer with peptide functionalized GQDs/hMSN nanoplatform
Source:
Springer Science and Business Media LLC
Normalizing Tumor Vessels To Increase the Enzyme-Induced Retention and Targeting of Gold Nanoparticle for Breast Cancer Imaging and Treatment
Source:
American Chemical Society (ACS)
Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
Source:
Elsevier BV
Perspectives on Dual Targeting Delivery Systems for Brain Tumors
Source:
Springer Science and Business Media LLC
Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy.
Source:
Elsevier BV
A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo
Source:
Proceedings of the National Academy of Sciences
A functional BRCA1 coding sequence genetic variant contributes to prognosis of triple-negative breast cancer, especially after radiotherapy
Source:
Springer Science and Business Media LLC
[Triple-negative breast cancer: molecular characteristics and potential therapeutic approaches].
Source:
Index Copernicus
Multi-targeting Peptide-Functionalized Nanoparticles Recognized Vasculogenic Mimicry, Tumor Neovasculature, and Glioma Cells for Enhanced Anti-glioma Therapy
Source:
American Chemical Society (ACS)
Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
Source:
Elsevier BV
Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer.
Source:
American Association for Cancer Research
Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer
Source:
Springer Science and Business Media LLC
Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
Source:
American Chemical Society (ACS)
Critical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in Cancer
Source:
American Society of Clinical Oncology (ASCO)
Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.
Source:
Elsevier BV
Notch-EGFR/HER2 Bidirectional Crosstalk in Breast Cancer.
Source:
Frontiers Media S.A.
Yiqi Formula Enhances the Antitumor Effects of Erlotinib for Treatment of Triple-Negative Breast Cancer Xenografts
Source:
Hindawi Publishing Corporation
Ligand-Mediated and Enzyme-Directed Precise Targeting and Retention for the Enhanced Treatment of Glioblastoma
Source:
American Chemical Society (ACS)
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.